Mature latin businessman showing stock market bar graph to businesswoman. Financial advising team discussing trading patterns of year. Rear view of casual businesspeople holding charts studying year trend together.

The share price of ACADIA Pharmaceuticals Inc. [NASDAQ: ACAD] inclined by $41.22, presently trading at $40.78. The company’s shares saw 209.64% gains compared to the lowest price in the period of the last 52 weeks, set at $13.17 recorded on 09/10/19. The last few days have been tough to the share price as ACAD jumped by +63.81% during the last week, even though the stock is still down by -7.48% compared to 15.85 of all time high it touched on 09/09/19. However, the stock had a strong performance during the past 3 months, roughly gaining 38.00%, while additionally gaining 193.59% during the last 12 months. ACADIA Pharmaceuticals Inc. is said to have a 12-month price target set at $33.75. That means that the stock has a strong potential to acquire -7.03% decrease from the current trading price.

ACADIA Pharmaceuticals Inc. [NASDAQ:ACAD]: Analyst Rating and Earnings

Its stock price has been found in the range of 13.17 to 43.98. This is compared to its latest closing price of $41.22.

Keep your eyes peeled for this company’s upcoming financial results publication, which is slated for Tue 5 Nov (In 55 Days).

Fundamental Analysis of ACADIA Pharmaceuticals Inc. [ACAD]

Now let’s turn to look at profitability: with a current Operating Margin for ACADIA Pharmaceuticals Inc. [ACAD] sitting at -110.56 and its Gross Margin at +94.47.

This company’s Return on Total Capital is -60.77, and its Return on Invested Capital has reached -51.90%. Its Return on Equity is -60.22, and its Return on Assets is -53.03. These metrics suggest that this ACADIA Pharmaceuticals Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

What about valuation? This company’s Enterprise Value to EBITDA is -12.56. The Enterprise Value to Sales for this firm is now 11.62. ACADIA Pharmaceuticals Inc. [ACAD] has a Price to Book Ratio of 4.86.

Shifting the focus to workforce efficiency, ACADIA Pharmaceuticals Inc. [ACAD] earns $520,481 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 9.68 and its Total Asset Turnover is 0.48. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 8.76 and its Current Ratio is 8.83. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

ACADIA Pharmaceuticals Inc. [ACAD] has 148.86M shares outstanding, amounting to a total market cap of $6.14B. Its stock price has been found in the range of 13.17 to 43.98. At its current price, it has moved down by -7.28% from its 52-week high, and it has moved up 209.64% from its 52-week low.

This stock’s Beta value is currently 2.75, which indicates that it is 9.04% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 75.66. This RSI suggests that ACADIA Pharmaceuticals Inc. is currently Overbought.

Conclusion: Is ACADIA Pharmaceuticals Inc. [ACAD] a Reliable Buy?

Shares of ACADIA Pharmaceuticals Inc. [ACAD], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.